# Pharmacokinetics and Safety Study of CTAP101 Capsules in Japanese and Non-Japanese Healthy Subjects and Non-Japanese Healthy Subjects

> **NCT03660800** · PHASE1 · COMPLETED · sponsor: **OPKO Health, Inc.** · enrollment: 67 (actual)

## Conditions studied

- Vitamin D Insufficiency
- Secondary Hyperparathyroidism

## Interventions

- **DRUG:** CTAP101 Capsules

## Key facts

- **NCT ID:** NCT03660800
- **Lead sponsor:** OPKO Health, Inc.
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2018-08-20
- **Primary completion:** 2018-10-24
- **Final completion:** 2019-01-22
- **Target enrollment:** 67 (ACTUAL)
- **Last updated:** 2019-09-30


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03660800

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03660800, "Pharmacokinetics and Safety Study of CTAP101 Capsules in Japanese and Non-Japanese Healthy Subjects and Non-Japanese Healthy Subjects". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT03660800. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*